What You Should Know:
- SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO.
- Fred will joins SubjectWell during a time of growth following the company’s Series B funding in November 2022, with the goal of accelerating technical solutions and building investor relations.
Fred Martin Bio
Fred brings more than 25 years of experience in
Read More
SubjectWell
Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals
What You Should Know:
- In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color.
- However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
SubjectWell Expands Its Clinical Trials Marketplace to United Kingdom, Ireland, and South Africa
- SubjectWell announced it is expanding its risk-free clinical trials marketplace into the United Kingdom, Ireland and South Africa. - With 86% of clinical trials operating sites outside of the U.S., the company continues to develop a more streamlined and complete risk-free patient recruitment offering, now with global reach. SubjectWell, an Austin, TX-based risk-free clinical trials marketplace announced it has expanded its patient recruitment services into the United Kingdom, Ireland, and
Read More
SubjectWell, Human API Partner to Provide Free Patient Medical Record Retrieval
- Risk-free clinical trial marketplace, SubjectWell partners with data-sharing platform Human API to provide free record retrieval to clinical trial sites and sponsors. - The risk-free clinical trials marketplace will use Human API’s platform to simplify patient-approved health data collection and speed up the randomization process.SubjectWell, the risk-free clinical trial marketplace has partnered with data-sharing platform Human API to provide free medical record retrieval to clinical trial
Read More
SubjectWell Raises $10M to Expand Risk-Free Clinical Trials Marketplace for Patient Recruitment
SubjectWell, an Austin, TX-based risk-free clinical trials marketplace for patient recruitment has raised $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund.
SubjectWell
Clinical Trials Marketplace
Founded in 2012, SubjectWell is increasing participation in clinical research by providing a single marketplace that allows prospective patients to match to any available clinical trials. Instead of using
Read More
